Dr. Simon’s current research foci include development of novel cancer therapeutics and optimizing therapy by integrating Artificial Intelligence platforms in therapeutic decision making in oncology. Some of his research has been funded by the National Cancer Institute (R21, R01), Department of Defense grants and other institutional funding mechanisms. Dr. Simon was also a part of a team of physicians who competed successfully for a Lung Cancer SPORE (Specialized Programs of Research Excellence), a multi-investigator NCI grant.

Additionally, Dr. Simon served as a reviewer for several panels of the National Institutes of Health and the National Cancer Institute, Department of Defense and Veterans Administration Merit Review Board. Internationally, Dr. Simon have also served as a grant reviewer for the NICE, UK and for granting organizations in Ireland, Italy, and Australia. Previously, Dr. Simon served as a member of American College of Chest Physicians and National Comprehensive Cancer Network (NCCN) Lung Cancer guidelines panels. Currently, he holds two active United States Patents. He also serves in the scientific advisory board for several biotech companies developing novel Therapies.

A respected voice in the fields of Thoracic Malignancies and Developmental Therapeutics, Dr. Simon has authored and co-authored numerous articles in peer reviewed journals as well as numerous book chapters. Throughout his career, Dr, Simon has strived to make an impact in the field of cancer medicine through patient care, teaching, and research.